Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis).
LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, was tested by reference methods against 2 collections of pathogenic Neisseria, N. gonorrhoeae (157 strains) and N. meningitidis (100 strains). The collection included strains resistant to penicillin, tetracycline, and fluoroquinolones and were also tested against ceftriaxone, ciprofloxacin, penicillin, and tetracycline. The 50% and 90% minimum inhibitory concentration values for LBM415 were 1 and 2 microg/mL, and 4 and 8 microg/mL for N. meningitidis and N. gonorrhoeae, respectively. All comparison agents were more active than this peptide deformylase inhibitor against this genus.
Jones
Ronald N
RN
The JONES Group, JMI Laboratories Inc., North Liberty, IA 52317, USA. ronald-jones@jmilabs.com
Sader
Helio S
HS
Fritsche
Thomas R
TR
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015169:Colony Count, Microbial; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects* / Q000302:isolation & purification; D009345:Neisseria meningitidis / Q000187:drug effects* / Q000302:isolation & purification; D010455:Peptides / Q000494:pharmacology*; D012494:Sampling Studies; D012680:Sensitivity and Specificity
D000900:Anti-Bacterial Agents; C487638:NVP PDF 713; D010455:Peptides